SCHEMBL29248273

SCHEMBL29248273

Fc1ccc[c]c1-c1ccc2ncoc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DYRK1A Q13627 2/20 0.46
▸ FFAR1 O14842 1/20 0.38
▸ PPARD Q03181 1/20 0.38
▸ PIK3CA P42336 2/20 0.36
▸ MTOR P42345 1/20 0.36
▸ NPC1 O15118 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ PIK3R1 P27986 1/20 0.34
▸ CTNNB1 P35222 2/20 0.34
▸ WNT3A P56704 2/20 0.34
▸ MAPK14 Q16539 2/20 0.33
▸ PRMT5 O14744 1/20 0.32
▸ WDR77 Q9BQA1 1/20 0.32
▸ PDE4A P27815 2/20 0.32
▸ PDE4B Q07343 2/20 0.32
▸ PDE4C Q08493 2/20 0.32
▸ PDE4D Q08499 2/20 0.32
▸ NAMPT P43490 1/20 0.32
▸ LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28360938 0.77 — —
SCHEMBL24425916 0.74 DYRK1A (0.72) DYRK1AFFAR1PPARDPIK3CAMTOR
SCHEMBL28172473 0.72 DYRK1A (0.60) DYRK1AFFAR1PPARDPIK3CAMTOR
SCHEMBL28357177 0.71 MAPK14 (0.49) DYRK1APIK3CAMTORNPC1RAB9A
SCHEMBL28360929 0.71 QPCT (0.47) NPC1RAB9ASMN1; SMN2CTNNB1WNT3A
SCHEMBL3424519 0.71 DYRK1A (0.49) DYRK1ANPC1RAB9ASMN1; SMN2PDE4A
SCHEMBL29689417 0.70 DYRK1A (0.62) DYRK1AFFAR1PPARDPIK3CAMTOR
SCHEMBL150096 0.67 MAOB (0.32) NPC1RAB9A
SCHEMBL1798498 0.67 DYRK1A (0.49) DYRK1APIK3CAMTORNPC1RAB9A
SCHEMBL28356989 0.67 MAPK14 (0.39) MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118317965-A Adenosine receptor antagonists 交信医药研发公司 2024-07-09 — — CN claimed
CN-118317965-A Adenosine receptor antagonists 交信医药研发公司 2024-07-09 — — CN disclosed
Send feedback